Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Drug abuse

Public Health England seeks to improve opioid substitution treatment

Public Health England (PHE) has launched an opioid treatment quality improvement programme, and will work with drug treatment providers to develop tools to improve the quality of substitution treatment.

The new PHE programme is intended to help drug services implement the government’s new drug misuse and dependence guidelines and improve treatment for drug users.

In a statement, PHE said the new programme will aim to “support services to improve the quality of treatment so that people understand how their treatment works, comply with it and stick with it.

“This will include a focus on using psychosocial interventions to support changes in behaviour.”

The programme will focus specifically on developing resources for services who are treating people who continue to use drugs (particularly heroin).

And PHE said the programme will also try to “enhance wider recovery support for those in treatment by supporting services to help other aspects of their lives beyond drug use, such as employment, living arrangements, family relationships, trauma and abuse.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20204388

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Oxycodone

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.